HCRT and Parkinson disease: Orexin receptor antagonists may help control sleep disturbances, which are common in PD patients; however, there is concern around the fact that they may worsen both motor and nonmotor symptoms by blocking orexin signaling pathways, which are critical for maintaining dopaminergic neuron function [22].